With retatrutide at the forefront of metabolic disorder research, having access to accurate and up-to-date information is critical to making informed decisions
10.2337/db12-0976 66
EMBO J 31(8):18531864 Federico A, Cardaioli E, Da Pozzo P, Formichi P, Gallus GN, Radi E (2012) Mitochondria, oxidative stress and neurodegeneration
10.2337/diabetes.47.4.530 117 ThorensB
Early healing acceleration
ABSTRACT INTRODUCTION SGLT2 INHIBITORS, CARDIOVASCULAR AND KIDNEY PROTECTION IN PATIENTS WITH T2DM GLP-1 RAs, CARDIOVASCULAR AND RENAL PROTECTION IN PATIENTS WITH T2DM NON-STEROIDAL MINERALOCORTICOID RECEPTOR ANTAGONISTS, CARDIOVASCULAR AND KIDNEY PROTECTION IN PATIENTS WITH T2DM COMBINED USE OF NOVEL AGENTS FOR THE TREATMENT OF DKD CONCLUSIONS Article information References ABSTRACT Over the last 5 years there have been many new developments in the management of diabetic kidney disease